In acute ischemic stroke mice, the Elane inhibitor agaphelin reduces thrombosis, inflammation, and damage to the blood-brain barrier, indicating that Elane is a promising target for ischemic stroke (Leinweber et al., 2021). The gene discussed is ELANE; the disease is ischemic stroke.